The inhibition of caspase-1 with y-Vad did not alter TGF-β levels after dA:dT administration (Figure 5C), suggesting that AIM2-induced TGF-β release from IPF patients-derived PBMCs was caspase-1 independent. The gene discussed is AIM2; the disease is idiopathic pulmonary fibrosis.